跳至主要内容
临床试验/NCT03431246
NCT03431246已完成3 期

Persistance of Anti-HPV After a Single Dose of Gardasil and the Effect of a Dose of Gardasil-9 When Administered 3-8 Years Later

Laval University2 个研究点 分布在 1 个国家目标入组 32 人开始时间: 2016年10月1日最近更新:
适应症
干预措施

试验速览

阶段
3 期
状态
已完成
入组人数
32
试验地点
2
主要终点
Anti-HPV seropositivity

研究概览

简要总结

This study will assess the immunogenicity of one dose of Gardasil and one dose of Gardasil-9

详细描述

This is a one group exploratory study.

The main objective of this study is to assess the persistance of anti-HPV after a single dose Gardasil and the effect of one dose of Gardasil-9 when administered 3-8 years later.

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Prevention
盲法
None

入排标准

年龄范围
12 Years 至 18 Years(Child, Adult)
性别
Female
接受健康志愿者

入选标准

  • Have received a single dose of Gardasil 3-8 years before recruitement.

排除标准

  • Immunossupressed or blood coagulation problems

研究组 & 干预措施

Gardasil and Gardasil-9

Experimental

干预措施: Gardasil and Gardasil-9 (Biological)

结局指标

主要结局

Anti-HPV seropositivity

时间窗: One month post vaccine administration.

Seropositivity to 9 HPV types included in Gardasil-9 vaccine will be assessed.

次要结局

  • HPV antibody titers(One month post vaccine administration)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Vladimir Gilca

Medical Epidemiologist

Laval University

研究点 (2)

Loading locations...

相似试验